ImmuCell appoints Kathy Turner to board, replacing retiring Steven Rosgen

IMMUCELL CORP /DE/

Steven Rosgen resigns from the board effective April 1, 2026, after 8 years of service.
Kathy Turner elected to board effective April 1; will chair Compensation Committee and serve on Audit Committee.
Turner brings 30+ years of animal health experience, including former Elanco board member and IDEXX/Abbott leadership roles.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.